Brazil questions transparency in Chinese coronavirus vaccine ‘emergency use’ approval

▴ Brazil questions transparency in Chinese coronavirus vaccine ‘emergency use’ approval
Brazilian health regulator Anvisa has said that Chinese health authorities had not been transparent in approving its COVID-19 vaccine ‘CoronaVac’ for emergency use.

CoronaVac, produced by the Chinese private laboratory Sinovac is currently undergoing phase 3 clinical trials in Sao Paulo.

The health regulator in a statement noted that while the vaccine has had an emergency use authorization in China since June, the country’s authorities have not been transparent about the criteria used for granting this authorization. Brazilian President Jair Bolsonaro has repeatedly cast doubt on the CoronaVac vaccine.

Sao Paulo Governor Joao Doria said the state expected to start vaccinating its residents in January, though Brazil’s most populous state will not be able to use CoronaVac until it is approved by Anvisa. China’s foreign ministry spokesman Wang Wenbin defended Coronavac’s development process, saying some countries had approved Chinese inoculations and termed it as a demonstration of the safety and effectiveness of China's vaccines.

As per reports, tens of thousands of people have taken the Sinovac vaccine in China’s emergency-use program that was approved for limited groups of high-risk category people.

Little information is publicly available about the approval process, scope, size, and scientific merit of the emergency-use program. Experts have raised concerns about safety and efficacy, both from a legal as well as ethical standpoint.

China has defended the use of experimental vaccines in this way saying the move was sanctioned by the World Health Organization (WHO).

Tags : #Brazil #LatestCOVIDVaccineNews17thDec #UnitetoFightCorona #LatestPharmaNews17thDec #China #Sinovac #Anvisa #WHO

About the Author

Team Medicircle

Related Stories

Loading Please wait...


Trending Now

Is Your Doctor’s Prescription Incomplete ? Insights from Recent ICMR Study Suggests So!April 13, 2024
Ministry of Health Dispels Misinformation on Medicine Price Surge from April 1April 13, 2024
India’s First Indigenous CAR T-Cell Therapy Launched By President Droupadi Murmu: A New Hope in Cancer TreatmentApril 12, 2024
Investigation Launched After Cataract Surgery Patients Experience Side-Effects in IndoreApril 12, 2024
The Reality of Protein Supplements in India: Mislabeling, Toxins, and Quality ChallengesApril 12, 2024
A Majority Of People Are Piling Up Weight Despite Adhering To A Healthy Lifestyle, Opt For These Vital Tests: ExpertsApril 11, 2024
Fighting Tuberculosis: IHLD and Krafton India Join Forces for Active Case DetectionApril 11, 2024
ICMR Study Reveals Blood Pressure Monitoring Gaps in IndiaApril 11, 2024
Innovative Procedure at KGMU Saves Man Impaled by Iron Rod: Beating Heart Surgery SuccessApril 11, 2024
Heart-Healthy Choices: How Salt Substitutes Can Prolong Your LifeApril 11, 2024
Unveiling Cancer Patterns in Families of Men with Fertility ChallengesApril 11, 2024
10 secrets of Successful Healthcare Branding and advertising campaignsApril 10, 2024
Global Hepatitis Crisis: India Ranks Second in Cases – WHO Report 2024April 10, 2024
Accelerated Ageing and Cancer Risk: New Perspectives from AACR 2024April 10, 2024
Man Hospitalized with Rare Bacterial Infection After Rat Bite: What You Need to KnowApril 10, 2024
Enhanced rock weathering results in higher crop yields and improved crop healthApril 09, 2024
Unlocking Health and Wealth - The Intersection of Digital Innovation in Healthcare and Finance for a Resilient IndiaApril 09, 2024
University of Exeter announces scholarships valued at over £10,000 for Indian StudentsApril 09, 2024
Thai Lion Air Extends Ground Handling Partnership with Çelebi India for Handling Cochin OperationsApril 09, 2024
Inclusion Carnival Illuminates Abilities and Awareness: A Vibrant Celebration of DiversityApril 08, 2024